What is Biospatial?
Headquartered in Research Triangle Park, NC, Biospatial operates as a leading healthcare analytics business. Its core strength lies in an expansive data network that grants near real-time access to electronic patient care reports (ePCRs) from thousands of Emergency Medical Services (EMS) providers across more than 40 US states. By integrating a growing database of 100 million EMS ePCRs with other healthcare data sources, Biospatial leverages proprietary artificial intelligence to serve customers in several data-intensive industries. The company's objective is to enhance situational awareness, inform critical decisions, and ultimately improve patient outcomes through sophisticated data analysis.
How much funding has Biospatial raised?
Biospatial has raised a total of $3.4M across 1 funding round:
Series A
$3.4M
Series A (2022): $3.4M with participation from East Carolina Angels, Gratus Private Capital, Front Porch Ventures, and Cofounders Capital
Key Investors in Biospatial
East Carolina Angels
East Carolina Angels is an angel investment group likely focused on supporting early-stage companies, particularly those within the North Carolina region, aligning with Biospatial's headquarters.
Cofounders Capital
Cofounders Capital is a venture capital fund specializing in seed-stage B2B software companies in the Southeast, indicating a strategic interest in technology-driven businesses with scalable models.
Front Porch Ventures
Front Porch Ventures appears to be an investment entity with a broad scope, potentially including real estate, but its participation in this funding round suggests an interest in diverse investment opportunities, possibly including technology or data-focused ventures.
What's next for Biospatial?
With its recent major strategic investment, Biospatial is poised for significant expansion and further development of its AI-driven analytics platform. This Series A funding is expected to fuel enhancements in data acquisition, processing capabilities, and the expansion of its customer base across various large industries reliant on real-time healthcare insights. The company's focus on ePCR data integration positions it to capitalize on the growing need for granular, actionable information within the healthcare ecosystem, potentially leading to new product offerings and market penetration.
See full Biospatial company page
